Intestinal tumor prevention
The global population of intestinal tumors is very large, with 1.93 million new cases of colon and rectal cancer and 916,000 deaths in 2020, according to statistics from the World Health Organization (WHO). Intestinal tumors have a significant impact on the health and quality of life of people worldwide. Early detection and treatment of intestinal tumors can significantly improve patients' survival rate and quality of life. Therefore, it is essential to strengthen the prevention, screening, and treatment of intestinal tumors.
Xiamen wiz biotech co., ltd. is the first manufacturer in China to obtain the registration certificate for calcareous protein and has launched the Diagnostic Kit for Calprotectin (Colloidal Gold) and Diagnostic Kit for Calprotectin (Fluorescence Immunochromatographic Assay), which are safe and more acceptable to patients. WIZ provides portable immune analyzer WIZ-A101, continuous immune analyzer WIZ-A202, and automatic immune analyzer WIZ-A301 to meet the testing needs of primary, secondary, and tertiary hospitals. As long as 10-15 minutes to interpret the results, can also be short-term continuous detection, to solve the problem of colonoscopy is difficult to short-term monitoring, is a more ideal intestinal disease screening and treatment, relapse detection means.
If you are interested, please contact WIZ's sales for further information.
